Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10140)
◆英語タイトル:Sopharma AD (3JR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10140
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ブルガリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholitin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Sopharma AD (3JR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma AD, Pharmaceuticals & Healthcare, Deal Details 10
Acquisition 10
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD – Key Competitors 14
Sopharma AD – Key Employees 15
Sopharma AD – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Product News 18
03/08/2017: Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference (“SRNT”) 18
02/20/2018: Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study 19
Clinical Trials 20
Nov 14, 2017: Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects 20
Oct 04, 2017: Achieve Announces Advancement of Cytisine Clinical Development Program 21
Aug 16, 2017: Achieve Announces Initiation of Cytisine Clinical Development Program 22
Aug 10, 2017: Achieve Announces FDA Acceptance of the Investigational New Drug Application for Cytisine as a Smoking Cessation Treatment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sopharma AD, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD, Key Competitors 14
Sopharma AD, Key Employees 15
Sopharma AD, Subsidiaries 16
Sopharma AD, Joint Venture 17

List of Figures
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報(Sopharma AD (3JR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆